시장보고서
상품코드
2075411

뉴로테크 기기 시장 : 제품 유형별, 질환별, 최종사용자별, 지역별

Neurotech Devices Market, By Product Type, By Condition, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,563,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,209,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 14,585,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뉴로테크 기기 시장은 2026년에 151억 5,120만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 310억 10만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 10.8%로 성장할 것으로 전망되고 있습니다.

분석 범위 분석 상세
기준연도 2025년 시장 규모(2026년) 151억 5,120만 달러
실적 데이터 2020-2024년 예측 기간 2026-2033년
예측 기간의 CAGR(2026-2033년) 10.80% 예측 금액(2033년) 310억 10만 달러

뉴로테크 기기는 신경계와 직접 인터페이스를 구축함으로써 다양한 신경질환의 치료를 목표로 하고 있습니다. 이러한 혁신적인 기술은 이식형 또는 웨어러블형 센서 및 자극 장치를 활용하여 신경 데이터를 수집하는 동시에, 뇌와 척수의 손상된 신경 경로를 복원할 가능성을 지니고 있습니다. 알츠하이머병, 파킨슨병, 간질, 만성 통증 등 기존 치료법으로는 치료가 어렵다고 여겨져 온 질환에 대해서도, 표적을 정확히 겨냥한 신경조절 접근법을 통해 개선이 기대됩니다. 전 세계 뉴로테크 기기 시장은 여전히 초기 단계에 있지만, 신제품들이 임상 시험 단계에 접어들면서 급속히 성장하고 있습니다. 첨단 소재와 전자 기기의 소형화 덕분에 생체 적합성을 갖춘 신경 인터페이스의 개발이 가능해졌습니다. 신경질환에 대한 대중의 인식 제고와 신경과학 연구에 대한 정부의 지원 확대는 향후 수년간 이 시장의 지속적인 성장을 촉진할 것으로 예상되는 주요 요인 중 일부입니다.

시장 역학 :

뉴로테크 기기 시장은 전 세계 신경질환 유병률의 증가, 신경 인터페이스 기술의 발전, 최소 침습 치료에 대한 수요 증가, 그리고 신경과학 연구에 대한 정부 자금 지원 확대에 힘입어 성장하고 있습니다. 그러나 임상 시험 및 제품 개발에 수반되는 높은 비용, 신기술의 보험 적용과 관련된 과제, 장기간 기기 이식에 따른 생물학적 안전성 우려 등의 요인이 시장 성장에 있으며, 큰 과제로 대두되고 있습니다. 또한 다양한 스타트업과 대기업도 치료 분야를 넘어선 신경기술의 응용, 예를 들어 인지 기능 확장(augmented cognition)과 같은 분야에서의 활용을 모색하기 시작했으며, 여기에는 수익성이 높은 상업적 기회가 존재합니다. 연구자, 의료기기 제조업체, IT 기업 간의 협력을 통해 차세대 신경기술 솔루션의 개발이 더욱 가속화될 것으로 예상됩니다.

이 보고서의 주요 특징 :

  • 이 보고서에서는 다양한 부문의 잠재적 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
  • 또한 이 보고서에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
  • 이 보고서에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)을 바탕으로 전 세계 뉴로테크 기기 시장의 주요 기업 개요을 소개하고 있습니다.
  • 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
  • 이 '세계의 뉴로테크 기기 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자 여러분은 전 세계 뉴로테크 기기 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 뉴로테크 기기 시장 : 제품 유형별(2021-2033년)

제5장 세계의 뉴로테크 기기 시장 : 질환별(2021-2033년)

제6장 세계의 뉴로테크 기기 시장 : 최종사용자별(2021-2033년)

제7장 세계의 뉴로테크 기기 시장 : 지역별(2021-2033년)

제8장 경쟁 구도

제9장 섹션

KSA 26.07.08

Neurotech Devices Market is estimated to be valued at USD 15,151.2 Mn in 2026 and is expected to reach USD 31,000.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 15,151.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.80% 2033 Value Projection: USD 31,000.1 Mn

Neurotech devices aim to treat a variety of neurological disorders by interfacing directly with the nervous system. These innovative technologies utilize implantable or wearable sensors and stimulating devices to collect neural data and potentially repair damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. The global neurotech devices market is still at a nascent stage but growing rapidly as new products enter clinical trials. Advanced materials and miniaturization of electronics have enabled the creation of biocompatible neural interfaces. Rising public awareness about neurological illnesses and growing government support for neuroscience research are some of the key factors anticipated to drive continued expansion of this market in the coming years.

Market Dynamics:

The neurotech devices market is driven by the rising global prevalence of neurological disorders, technological advancements in neural interfaces, growing demand for minimally invasive therapies, and increasing government funding for neuroscience research. However, factors such as high costs associated with clinical trials and product development, reimbursement challenges for new technologies, and biosafety concerns pertaining to long term device implantation pose significant challenges to market growth. Various startups and large companies have also started exploring applications of neurotech beyond therapeutics, in areas like augmented cognition, which presents lucrative commercial opportunities. Collaborations between researchers, medical device firms, and computing companies are likely to further accelerate the development of next-generation neurotech solutions.

Key features of the study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neurotech devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, and Advanced Bionics AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neurotech devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurotech devices market.

Detailed Segmentation:

  • Global Neurotech Devices Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Neurostimulation
  • Deep brain stimulator
  • Gastric electric stimulator
  • Spinal cord stimulator
  • Sacral nerve stimulator
  • Vagus nerve stimulator
  • Transcutaneous electrical nerve stimulation (TENS)
  • Other neurostimulations
  • Neuroprostheses
  • Neurosensing
  • Neurorehabilitation devices
  • Global Neurotech Devices Market, By Conditions (Revenue, USD Bn, 2021 - 2033)
  • Pain management
  • Cognitive disorders
  • Epilepsy
  • Urinary and fecal incontinence
  • Hearing conditions
  • Parkinson's disease
  • Depression
  • Sleep disorders
  • Essential tremor
  • Other conditions
  • Global Neurotech Devices Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Ambulatory surgical centers
  • Homecare facilities
  • Other end users
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in the Global Neurotech Devices Market:
  • Boston Scientific Corporation
  • BrainCo, Inc
  • Cochlear Limited
  • Control Bionics, Inc
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • Natus medical Incorporated
  • Integra LifeSciences
  • Blackrock Microsystems
  • NeuroSigma, Inc.
  • NeuroVigil Inc.
  • Neuralink Corp.
  • Abbott Laboratories
  • Advanced Bionics AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Conditions
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of neurological disorders
    • Integration of AI & IoT in neurotech devices
    • High cost of neurotech devices
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Neurotech Devices Market, By Product Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Deep brain stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Gastric electric stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Spinal cord stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Sacral nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Vagus nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Transcutaneous electrical nerve stimulation (TENS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other neurostimulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Neuroprostheses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Neurosensing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Neurorehabilitation devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Neurotech Devices Market, By Conditions, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pain management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Cognitive disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Urinary and fecal incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Hearing conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Parkinson's disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Sleep disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Essential tremor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Neurotech Devices Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Ambulatory surgical centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Homecare facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other end users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Neurotech Devices Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$)
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profile
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BrainCo, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Cochlear Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Control Bionics, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • LivaNova PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Nihon Kohden Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Natus medical Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Integra LifeSciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Blackrock Microsystems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • NeuroSigma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • NeuroVigil Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Neuralink Corp.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Advanced Bionics AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기